CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to HSCS

Sacubitril, Valsartan 97-103 mg Oral Tablet

Phase 2
HeartSciences Inc. (HSCS)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
HSCSPhase 2

Sacubitril, Valsartan 97-103 mg Oral Tablet Phase 2 Est. Readout

Sacubitril, Valsartan 97-103 mg Oral Tablet
Dec 2026~
CT.gov
00%
Drug Information

Target Indication

Diabetes Mellitus

Clinical Trial

NCT04055428

Last updated: 9/23/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.